Please login to the form below
Opportunity
This page shows the latest Opportunity news and features for those working in and with pharma, biotech and healthcare.
UK biotech Synairgen treats first patient in phase 3 COVID-19 trial
We believe this trial presents an opportunity for a significant UK scientific breakthrough and, if given the right support, our drug could rapidly assist with the global crisis,” he added.
Latest news
-
bluebird bio to separate oncology and rare diseases units
today. “We are excited and energised to begin this new year with so much opportunity ahead.
-
Pfizer/BioNTech to offer COVID-19 vaccine to placebo recipients
Pfizer and BioNTech, who said that they had secured enough vaccine doses for placebo recipients, aim to offer the opportunity to all eligible participants within the study by 1 March 2021.
-
Moderna scores FDA panel backing for mRNA-based COVID-19 vaccine
We were grateful for the opportunity to present the clinical data package for our mRNA vaccine against COVID-19 to the FDA’s advisory committee today.
-
Gilead set to acquire hepatitis specialist MYR for €1.15bn
HDV is a devastating disease with high unmet medical need. With Hepcludex we have the opportunity to address that need with a first-in-class therapy,” said Daniel O’Day, chairman
-
Bayer strengthens cell and gene therapy focus with new platform
Bayer will seek to strengthen its own internal cell and gene therapy capabilities, with the newly established platform also enabling it to pursue external opportunities to bolster its presence in this ... The emerging bio revolution represents a once-in-a
More from news
Approximately 0 fully matching, plus 2,191 partially matching documents found.
Latest Intelligence
-
2021: the year of decentralisation in drug development
Here we discuss the opportunities that decentralised and hybrid trial models bring to patients and the broader healthcare industry.
-
Successful product commercialisation: what can we learn from the rare disease setting?
Achieving launch success in an increasingly challenging commercial environment. The pharmaceutical industry is constantly evaluating opportunities to accelerate product life cycles and bring efficiencies to drug discovery, development and
-
After years of potential, cell and gene therapy is ready for the pharmaceutical mainstream
Now, these companies are aiming to give themselves ample opportunity to acquire, partner and strengthen their hand in the C> space.
-
Can digital communications boost behaviour change?
Technology offers unprecedented opportunities to reach, monitor and keep users on track, and it is encouraging to see public health bodies embracing the digital revolution. ... Support can be provided at steps in the journey when people are most receptive
-
Rebranding in an evolving world
With our brand identity firmly in place, next year will be an opportunity to refine our strategy to ensure we remain on track to reach the corporate targets that we set
More from intelligence
Approximately 0 fully matching, plus 587 partially matching documents found.
Latest appointments
-
Nucleus Global announces a trio of promotions
many opportunities that our collaboration with Huntsworth will afford us," he added.
-
New faces at HCA, P\S\L Group and Health Unlimited
I’m delighted to have the opportunity to be joining RxY. This offering is truly unique in our industry, filling a void that has long been a pain point for brand
-
McCann Health London bolsters creative leadership team
It's a huge privilege to have the opportunity to guide this talented, award-winning team towards more breakthrough work,” said Swimer.
-
PM Society announces new co-chairs for 2020
Having both worked in pharma for over 20 years, we are passionate about providing education and support to the industry and are delighted to have the opportunity to help the PM
-
New hires at FibroGen, Saniona and Turbine
This is a tremendously exciting time for FibroGen and I am grateful to have the opportunity to work with this team as we continue to apply groundbreaking science with the goal
More from appointments
Approximately 0 fully matching, plus 250 partially matching documents found.
Latest from PMHub
-
Don’t let COVID-19 put the brakes on your career
One considerable upside of the COVID-19 crisis is the opportunity to reflect on our lives and what’s important to us. ... At this time, some companies are providing more opportunity and security than others.
-
Patient Partnerships: Challenges and Opportunities for Pharma
In the latest episode of Impetus Digital's Fireside Chat, I sit down with Durhane Wong-Rieger, President &CEO of the Canadian Organization for Rare Disorders. We explore a range of topics related to rare disease treatment and advocacy, including how
-
‘Moving during a global pandemic was the best professional decision I could have made’
This time has given me the opportunity to identify the best fit for me in terms of agency, therapy area and team both professionally and personally.”. ... Then go for it!”. ------------------------------. If you are considering a change in your career
-
Top 10 Tips for Creating Company Culture in a Virtual World
an opportunity to grow and create something even better than what you currently have.
-
Porphyria Awareness Week – Round Up
Porphyria Awareness Week has given the team at emotive an opportunity to show our support for those touched by this debilitating Rare Disease as well as our enthusiasm for working in ... For more information on opportunities to work with emotive or to
More from PMHub
Approximately 2 fully matching, plus 659 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Account Manager Healthcare / Pharmaceutical Sector
-
Negotiable Salary
-
Healthcare Account Director
-
Competitive
- Sales Director, Healthcare communications agency, London/ SE UK
-
Six figure salary
-
Medical Editor
-
Competitive
-
Healthcare Lead Copywriter
-
Competitive
-
Healthcare Senior Account Manager
-
Competitive
- Sinovac’s COVID-19 vaccine appears safe in older adults
- Celltrion’s investigational mAb cuts COVID-19 recovery time
- COVID-19 vaccine developers respond to new strain
- Inovio plans late-stage COVID-19 vaccine study in second quarter 2021
- AZ’s COVID-19 vaccine trial to continue after Brazilian volunteer death
- bluebird bio to separate oncology and rare diseases units
- Live Webinar: COVID-19 Has Changed Live Events Forever!
- New hire and promotions announced at Evoke KYNE
- Amgen strikes $240m autoimmune deal with Evoq Therapeutics
- Lucid Group bolster its talent with a further twelve new starters for 2021
- UK pharmacies to begin administering COVID-19 vaccinations
- PHE study finds people who have had COVID-19 can still transmit the virus
PMHub
Cuttsy + Cuttsy
How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...
Latest intelligence
- AstraZeneca’s focus on diagnosing and managing chronic kidney disease
- People living with chronic kidney disease are in urgent need of new and improved approaches to diagnosis and care...
- Delphi Technique Virtual Co-creation: A Customer Story
- How a client leveraged the Delphi technique to co-create a consensus statement and algorithm using virtual touchpoints....
- Three ways AI will change healthcare in the next decade
- Looking forward, there is no doubt that AI will continue to take centre stage in global healthcare initiatives...
Quick links
Infographics
